-
Blebbistatin: Mechanism, Uses, and Assay Limits
2026-08-30
(±)-Blebbistatin is a cell-permeable non-muscle myosin II inhibitor that targets the myosin-ADP-Pi intermediate and suppresses actin-activated ATPase activity. Its reversible control of contractility makes Blebbistatin useful for cell migration, adhesion, morphology, and cytoskeletal dynamics assays, but isoform selectivity, solvent handling, and assay-specific potency must be controlled.
-
Olaparib: DNA Repair Meets Immune Reprogramming
2026-08-29
Olaparib and AZD2281 are moving beyond a narrow DNA repair narrative. This thought-leadership guide connects PARP-1/2 inhibition with BRCA-context biology, tumor radiosensitization studies, and emerging combination strategies that address T cell exhaustion in BRCA1-deficient ovarian cancer.
-
Berberine Targets RAGE/POMC in Metabolic Disease
2026-08-28
A 2026 pre-proof study identifies RAGE as a central nervous system target of berberine within Tianhuang Formula and connects RAGE/POMC signaling with hypothalamic neuronal apoptosis, autophagy, and glucolipid regulation. Its integrated computational, cellular, and mouse-model design provides a useful framework for studying neuronal mechanisms of metabolic disease while leaving translation to neurodegenerative disorders unresolved.
-
SAN-Plexus Assembloids and Pacemaker Maturation
2026-08-28
This Cell Stem Cell study develops human pluripotent stem cell-derived sinoatrial node–cardiac plexus assembloids that reproduce key structural, molecular, and electrophysiological features of neuro-modulated pacemaker systems. By combining assembloid function with spatial transcriptomics of human sinoatrial node tissue, the authors identify a prosaposin–GPR37 signaling axis associated with pacemaker maturation and establish a platform for studying conduction dysfunction.
-
Tetrazolium (chloride) Workflows for Viability
2026-08-27
Tetrazolium (chloride), also called Tetrazolium Red, converts mitochondrial dehydrogenase activity into a visible red formazan signal for cell and tissue analysis. This guide connects plate-based viability assays with ischemic brain staining, emphasizing controls, quantification, and troubleshooting rather than treating color intensity as a standalone mechanistic answer.
-
RBMS1 Loss Rewires PD-L1 Immunity in TNBC
2026-08-27
The reference study identifies RBMS1 as an RNA-binding protein that sustains PD-L1 stability in immune-cold triple-negative breast cancer through B4GALT1-dependent glycosylation. Its depletion increased tumor-cell susceptibility to T-cell attack and improved responses to immune-based treatments, providing a mechanistic framework for combination strategies.
-
Carboplatin Workflows for Cancer Research
2026-08-26
Carboplatin is a platinum-based DNA synthesis inhibitor that supports reproducible cytotoxicity, DNA-damage, and resistance studies across ovarian and lung cancer models. This workflow emphasizes stock preparation, matched 2D–3D testing, proteomics-informed interpretation, and troubleshooting for variable drug response.
-
Serine/Glycine-Free Diet in CRC Immunity
2026-08-26
Tong et al. show that a serine/glycine-free diet can restrict colorectal cancer growth while increasing cytotoxic T-cell activity, yet simultaneously promote immune escape through PD-L1 lactylation. The study links dietary metabolism to checkpoint regulation and provides early clinical evidence that this intervention is feasible and safe, supporting combination strategies rather than diet-only treatment.
-
HLTP1 Targets JNK in Hepatic Ischemia–Reperfusion Injury
2026-08-25
A 2026 World Journal of Gastroenterology study used peptidomics of human liver-transplant samples to identify human liver transplantation peptide 1 (HLTP1), an endogenous peptide that reduced hepatic ischemia-reperfusion injury in mice and protected AML12 hepatocytes. The findings connect HLTP1 activity to suppressed Jun N-terminal kinase phosphorylation and provide a mechanistically testable framework for studying apoptosis during liver transplantation.
-
Polymyxin B in CREC Assay Design
2026-08-25
Polymyxin B sulfate can do more than suppress Gram-negative bacteria: it can help researchers dissect membrane vulnerability, immune readouts, and resistance transmission. This guide translates recent CREC genomic epidemiology into a practical, evidence-aware assay strategy.
-
5X Protein Loading Buffer (Reducing) Guide
2026-08-24
5X Protein Loading Buffer (Reducing) standardizes denaturation, disulfide-bond reduction, and tracking-dye addition before conventional SDS-PAGE electrophoresis. It is intended for reducing, denaturing protein molecular weight separation and should not be used when native structure or intact disulfide bonds must be preserved.
-
7-dehydro Cholesterol: From Sterol to Assay
2026-08-24
7-dehydro Cholesterol is more than a cholesterol precursor: it is a photoreactive and oxidation-sensitive metabolic state variable. This article explains how to use 7-dehydrocholesterol in cholesterol biosynthesis research, vitamin D3 synthesis research, and mechanistic studies inspired by DHCR7-dependent antiviral phenotypes.
-
Protecting Mitocytosis Signals in Tumor Lysates
2026-08-23
Mitocytosis research shows how tumor cells can expel damaged mitochondria through migrasomes and evade mitochondrial stress. This article explains why protease control is essential when translating those findings into reliable protein assays, and how an EDTA-free, broad-spectrum cocktail can support phosphorylation analysis, Western blotting, and protein-complex workflows without confusing sample preservation with biological intervention.
-
SN-38 Disrupts FUBP1–FUSE DNA Binding
2026-08-22
The reference study identified camptothecin and SN-38 as inhibitors of the FUBP1–FUSE interaction, revealing a regulatory mechanism that complements topoisomerase I poisoning. Its biochemical screening and hepatocellular carcinoma validation connect a well-known cytotoxic drug class with direct interference in an oncogenic transcriptional pathway.
-
γH2AX DNA Damage Detection Kit for FLASH-RT
2026-08-22
Translate radiation, nanoparticle, and genotoxicity experiments into measurable nuclear damage using red γ-H2AX foci and DAPI counterstaining. This workflow combines practical optimization, quantitative imaging, and controls for distinguishing transient DNA damage from persistent repair failure or apoptosis.